Description

ETHAMSIG 500 TAB is a formulation of Ethamsylate 500 mg, a non-hormonal hemostatic agent that promotes capillary endothelial stability and enhances platelet adhesion to help reduce bleeding time. It is commonly prescribed for the prevention and control of abnormal or heavy bleeding, particularly in surgical, gynecological, dental, and ENT procedures.

Ethamsylate works by improving platelet aggregation and restoring capillary resistance without interfering with the clotting cascade. It is useful in both acute and chronic hemorrhagic conditions.

Therapeutic Uses:

• Heavy menstrual bleeding (menorrhagia)

• Pre- and post-operative bleeding control

• Dental surgery, ENT procedures, and minor trauma

• Prevention of intracranial hemorrhage in neonates

• Bleeding disorders associated with capillary fragility

Key Benefits:

• Non-hormonal control of bleeding

• Enhances platelet adhesion and capillary strength

• Well-tolerated in gynecological and surgical settings

• Fast onset of action and proven safety profile

• Suitable for both acute and preventive use

Manufactured in WHO-GMP and ISO-certified facilities, ETHAMSIG 500 TAB is distributed internationally by BLUEPILL EXPRESS, a reliable pharmaceutical exporter with reach across Asia, Africa, the Middle East, Europe, and Latin America. Complete export documentation and regulatory support are included with every shipment.